EC Gynaecology

Case Report Volume 15 Issue 7 - 2026

Leveraging Ethiopia’s HIV Prevention Success to Strengthen Neural Tube Defect Prevention and Maternal Health

Muleta Befkene Wayessa1* and Heran Ararsa Nigirti2

1Department of Obstetrics and Gynecology, Yekatit 12 Medical College at Abebech Gobena Maternal and Child Health Hospital, Addis Ababa, Ethiopia
2Department of Obstetrics and Gynecology, Adama Hospital Medical College, Adama, Oromia, Ethiopia

*Corresponding Author: Muleta Befkene Wayessa, Assistant Professor of Gynecology and Obstetrics, Fetomaternal Fellow, Department of Obstetrics and Gynecology, Yekatit 12 Medical College at Abebech Gobena Maternal and Child Health Hospital, Addis Ababa, Ethiopia.
Received: June 23, 2026; Published: June 30, 2026



Neural tube defects (NTDs) remain a significant cause of neonatal mortality, disability, and adverse maternal-child health outcomes, despite strong evidence that periconceptional folic acid supplementation and food fortification can prevent most cases. In Ethiopia, recent advances in preconception care, micronutrient supplementation, and mandatory food fortification have strengthened efforts to prevent NTDs; however, these interventions remain insufficiently integrated across the continuum of care. In contrast, Ethiopia’s Prevention of Mother-to-Child Transmission (PMTCT) program has achieved notable success through the implementation of the World Health Organization’s four-prong HIV prevention framework. This commentary proposes adapting that proven framework to NTD prevention by focusing on: (1) preventing unintended pregnancies among at-risk women, (2) preventing NTDs during pregnancy through folic acid supplementation, fortification, counseling, and screening, (3) preventing recurrence among high-risk women, and (4) providing treatment, rehabilitation, and psychosocial support for affected children and their families. By drawing on lessons from Ethiopia’s HIV response, we argue that adopting a four-prong approach could strengthen policy integration, improve maternal and child health outcomes, and accelerate progress toward reducing the burden of NTDs.

Keywords: Folic Acid; Maternal Health; Neural Tube Defects; PMTCT; Preconception Care

  1. Laurence KM., et al. “The role of preconceptional vitamin supplementation in the prevention of recurrent neural tube defects”. Lancet 8229 (1981): 871-872.
  2. MRC Vitamin Study Research Group. “Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study”. Lancet8760 (1991): 131-137.
  3. “Guideline: Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects”. Geneva: World Health Organization (2015).
  4. Centers for Disease Control and Prevention (CDC). “Folic acid helps prevent neural tube defects”. U.S. Department of Health & Human Services (2020).
  5. Williams J., et al. “Impact of folic acid fortification on neural tube defects: a global perspective”. Public Health Reviews1 (2015): 1-15.
  6. Adeleye AO., et al. “Knowledge, attitude, and practice of folic acid supplementation among pregnant women in Ibadan, Nigeria”. Nigerian Journal of Clinical Practice2 (2010): 134-138.
  7. Wanyonyi WA., et al. “Malaria and geohelminthiasis coinfections in expectant women: Effect on maternal health and birth outcomes in a malaria endemic region in Kenya”. PLOS Neglected Tropical Diseases12 (2018): e0006946.
  8. Federal Ministry of Health [Ethiopia]. National Nutrition Program II (2016-2020) Addis Ababa: Government of the Federal Democratic Republic of Ethiopia (2016).
  9. “Seqota Declaration: Ending Child Undernutrition by 2030”. Addis Ababa: Government of Ethiopia (2015).
  10. Ethiopian Public Health Institute. “Preconception care implementation framework in Ethiopia”. Addis Ababa: EPHI (2019).
  11. Abebe H., et al. “Knowledge, attitude, and practice towards PMTCT among antenatal care attendees in Ethiopia”. International Journal of Current Research8 (2019): 6530-6534.
  12. Czeizel AE and Dudás I. “Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation”. New England Journal of Medicine 26 (1992): 1832-1835.
  13. Yerby AS. “Disability and public health policy”. In: Albrecht GL, Seelman KD, Bury M, editors. Handbook of Disability Studies. Thousand Oaks (CA): Sage Publications (2000): 698‑
  14. Correa A and Nobre AC. “Neural modulation by regularity and passage of time”. Journal of Neurophysiology 3 (2008): 1649‑1655.
  15. De Regil LM., et al. “Daily oral folic acid supplementation during pregnancy”. Cochrane Database of Systematic Reviews 10 (2010).
  16. Berhane A., et al. “Prevalence and associated factors of neural tube defects in Addis Ababa hospitals, Ethiopia”. BMC Pregnancy and Childbirth1 (2019): 380.
  17. Taye B., et al. “Neglected tropical diseases as a ‘litmus test’ for universal health coverage? Understanding who is left behind and why in mass drug administration: Lessons from four country contexts”. PLOS Neglected Tropical Diseases.
  18. Alemu AW., et al. “Mother‑to‑child HIV transmission and associated factors among HIV‑exposed infants in Ethiopia”. PLOS One6 (2020): e0234722.
  19. Nicolaides KH. “Screening for fetal abnormalities by ultrasound”. Prenatal Diagnosis1 (2011): 9-17.
  20. Salomon LJ., et al. “ISUOG practice guidelines: performance of first trimester fetal ultrasound scan”. Ultrasound in Obstetrics and Gynecology6 (2019): 715-723.
  21. Chitty LS and Pilu G. “Prenatal diagnosis of congenital anomalies”. Boca Raton (FL): CRC Press (2014): 456.
  22. International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). “Practice guidelines: routine mid trimester fetal anomaly scan”. Ultrasound in Obstetrics and Gynecology5 (2021): 715-726.
  23. Correa A., et al. “Teratogenic exposures and prevention of birth defects”. American Journal of Medical Genetics Part C 2 (2019): 173-182.
  24. Botto LD., et al. “Environmental exposures and neural tube defects: updated evidence”. Birth Defects Research3 (2021): 159-172.
  25. Sayed AR., et al. “Impact of folic acid fortification on neural tube defects in South Africa”. Public Health Nutrition1 (2020): 1-9.
  26. Federal Ministry of Health, Ethiopia (FMoH). “Basic Obstetrics Ultrasound Training for Ethiopian Obstetric Care Providers”. Addis Ababa (2024).
  27. Abebe KG., et al. “Knowledge, attitude, prevention practice and lived experience towards cutaneous leishmaniasis and associated factors among residents of Kutaber district, Northeast Ethiopia: A mixed method study”. PLOS Neglected Tropical Diseases 8 (2022): e0012427.
  28. Mitchell J., et al. “Congenital anomalies and neglected tropical diseases: global burden and policy implications”. Geneva: World Health Organization. Report No.: WHO/NTD/2004.1 (2004).
  29. Bowman DD., et al. “Neglected tropical diseases: hidden successes, emerging opportunities”. Geneva: World Health Organization. Report No.: WHO/HTM/NTD/2009.2. ISBN: 9789241598705 (2009).
  30. Liptak GS and El Samra A. “Congenital anomalies and neglected tropical diseases: global perspectives on maternal and child health”. Geneva: World Health Organization. Report No.: WHO/NTD/2010.5 (2010).
  31. Wilkinson T., et al. “Surgery for neglected tropical diseases”. PLOS Neglected Tropical Diseases 6 (2014): e2929.

Muleta Befkene Wayessa and Heran Ararsa Nigirti. “Leveraging Ethiopia’s HIV Prevention Success to Strengthen Neural Tube Defect Prevention and Maternal Health”. EC Gynaecology 15.7 (2026): 01-05.